Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Plasma tau is increased in frontotemporal dementia

Open access

Abstract

Background: Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder presenting clinically with personality change (behavioural variant FTD (bvFTD)) or language deficits (primary progressive aphasia (PPA)). About a third of FTD is familial with mutations in GRN , MAPT and C9orf72 being the major genetic causes. Robust biomarkers of the underlying pathology are still lacking in FTD with no markers currently being able to distinguish those with tau and TDP-43 inclusions during life. Methods: This study used an ultrasensitive single molecule methodology to measure plasma tau concentrations in 176 participants: 71 with bvFTD, 83 with PPA and 22 healthy controls. The patient group included 36 with pathogenic mutations in either MAPT (n=12), GRN (n=9) or C9orf72 (n=15). Group comparisons were performed between clinical and genetic groups and controls using a linear regression model with bias-corrected bootstrap CIs. Correlative analyses were performed to investigate associations with measures of disease severity and progression. Results: Higher plasma tau concentrations were seen in bvFTD (mean 1.96 (SD 1.07) pg/mL) and PPA (2.65 (2.15) pg/mL) compared with controls (1.67 (0.50) pg/mL). Investigating the PPA group further showed significantly higher levels compared with controls in each of the PPA subtypes (non-fluent, semantic and logopenic variants, as well as a fourth group not meeting criteria for one of the three main variants). In the genetic groups, only the MAPT group had significantly increased concentrations (2.62 (1.39) pg/mL) compared with controls. No significant correlations were seen with cross-sectional or longitudinal brain volumes, serum neurofilament light chain concentrations or disease duration. Conclusion: Plasma tau levels are increased in FTD in all clinical groups, but in the genetic subtypes only in MAPT mutations, the group of patients who definitively have tau pathology at postmortem. Future studies will be required in pathologically confirmed cohorts to investigate this association further, and whether plasma tau will be helpful in differentiating patients with FTD with tau from those with other pathologies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp-2017-317260

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Plasma tau concentrations in participants comparing: (A) behavioural variant frontotemporal dementia (bvFTD), primary progressive aphasia (PPA) and healthy controls; (B) PPA subtypes: non-fluent variant (nfvPPA), semantic variant (svPPA), logopenic variant (lvPPA) and a group not fitting criteria for any of the three main variants, PPA-not otherwise specified (PPA-NOS) and (C) genetic subtypes: microtubule-associated protein tau (MAPT), C9orf72 and progranulin (GRN).
Figure 1 Plasma tau concentrations in participants comparing: (A) behavioural variant frontotemporal dementia (bvFTD), primary progressive aphasia (PPA) and healthy controls; (B) PPA subtypes: non-fluent variant (nfvPPA), semantic variant (svPPA), logopenic variant (lvPPA) and a group not fitting criteria for any of the three main variants, PPA-not otherwise specified (PPA-NOS) and (C) genetic subtypes: microtubule-associated protein tau (MAPT), C9orf72 and progranulin (GRN).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 70

Metadata

Authors
Foiani, M. S., Woollacott, I. O., Heller, C., Bocchetta, M., Heslegrave, A., Dick, K. M., Russell, L. L., Marshall, C. R., Mead, S., Schott, J. M., Fox, N. C., Warren, J. D., Zetterberg, H., & Rohrer, J. D.
Affiliations
  • UK Dementia Research Institute (GB)
  • UCL Queen Square Institute of Neurology (GB)
  • MRC Prion Unit (GB)
  • Sahlgrenska University Hospital (SE)
Corresponding author
Rohrer, Jonathan D
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2018-02-13
Volume
89
Issue
8
Pages
804-807
ISSN
  • 0022-3050 (ISSN-L)
  • 1468-330X
OpenAlex
W2786797583
Cited by
64
References
11
Citations by year
2026: 2 · 2025: 5 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 4
FWCI
7.28
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
Funders
  • Wellcome Trust
  • National Institute for Health Research
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal dementia, plasma tau, behavioral variant frontotemporal dementia, primary progressive aphasia, MAPT mutations, GRN mutations, C9orf72 mutation, tau pathology, TDP-43 pathology, disease biomarkers, single-molecule detection, neurodegeneration
MeSH terms
Aged, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Case-Control Studies, tau Proteins, Frontotemporal Dementia, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma tau is increased in frontotemporal dementia. https://app.cochat.ai/papers/10.1136/jnnp-2017-317260
The paper
Foiani, M. S., Woollacott, I. O., Heller, C., Bocchetta, M., Heslegrave, A., Dick, K. M., Russell, L. L., Marshall, C. R., Mead, S., Schott, J. M., Fox, N. C., Warren, J. D., Zetterberg, H., & Rohrer, J. D. (2018). Plasma tau is increased in frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2017-317260

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.